Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TBPH	THERAVANCE BIOPHARMA INC	$708.58M	6.90%	3.50%	11.49%	15.90%	0.90	6.71	100.00%	16.90%	55.25%
EMBC	EMBECTA CORP	$812.35M	-7.00%	4.40%	19.34%	7.60%	-2.52	2.48	63.50%	4.90%	15.42%
INFU	INFUSYSTEM HOLDINGS INC	$211.20M	9.10%	4.90%	12.11%	9.60%	0.85	2.19	54.50%	3.60%	7.36%
AVAH	AVEANNA HEALTHCARE HOLDINGS INC	$1.83B	-18.90%	1.10%	15.00%	13.30%	-148.62	1.09	33.30%	0.90%	9.35%
LIVN	LIVANOVA PLC	$2.92B	-17.70%	-8.40%	-7.27%	-13.90%	1.23	1.29	69.10%	-16.10%	-9.33%
AMRX	AMNEAL PHARMACEUTICALS INC	$3.06B	-3.00%	0.10%	12.55%	8.20%	-31.53	1.43	37.70%	0.10%	10.19%
RIGL	RIGEL PHARMACEUTICALS INC	$513.55M	438.90%	57.00%	88.99%	124.70%	1.52	2.02	91.50%	36.50%	39.89%
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.57B	18.30%	3.90%	9.61%	6.80%	3.76	2.76	30.90%	3.70%	7.91%
ARDT	ARDENT HEALTH INC	$1.90B	22.30%	5.20%	9.43%	8.10%	2.70	2.13	18.30%	4.10%	6.31%
GRFS	GRIFOLS SA	$6.75B	2.70%	0.70%	5.73%	5.80%	2.18	2.66	38.70%	2.20%	15.29%
BCRX	BIOCRYST PHARMACEUTICALS INC	$1.60B	N/A	-7.40%	22.20%	6.00%	-2.08	2.25	97.00%	-6.40%	11.15%
INDV	INDIVIOR PLC	$2.98B	-56.00%	8.90%	64.65%	78.00%	-6.65	0.90	84.00%	10.90%	21.81%
ANIP	ANI PHARMACEUTICALS INC	$2.02B	-5.40%	-1.90%	-0.83%	-1.00%	2.03	2.66	59.30%	-3.40%	-1.35%
AUPH	AURINIA PHARMACEUTICALS INC	$1.73B	16.70%	11.50%	15.80%	14.50%	0.50	5.23	89.50%	23.30%	25.77%
BVS	BIOVENTUS INC	$550.64M	-0.10%	0.00%	6.80%	8.10%	3.14	1.48	67.60%	0.00%	6.29%
HALO	HALOZYME THERAPEUTICS INC	$8.63B	136.60%	26.40%	36.99%	27.90%	5.17	8.36	84.20%	47.30%	60.25%
EHAB	ENHABIT INC	$410.67M	-24.00%	-10.70%	-8.67%	-14.00%	1.22	1.49	49.00%	-13.40%	-9.19%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.34B	11.50%	9.20%	12.57%	15.10%	0.24	5.56	79.60%	21.50%	27.78%
IRWD	IRONWOOD PHARMACEUTICALS INC	$225.78M	N/A	-2.20%	70.34%	10.10%	-2.11	0.83	100.00%	-2.60%	25.18%
STE	STERIS PLC	$24.53B	9.70%	6.30%	9.72%	17.30%	0.49	2.22	44.10%	11.60%	16.54%
TBRG	TRUBRIDGE INC	$307.59M	-5.80%	-2.50%	6.18%	9.80%	1.25	1.80	52.80%	-2.80%	6.04%
SIGA	SIGA TECHNOLOGIES INC	$655.91M	40.50%	35.60%	50.40%	194.00%	0.12	10.09	76.90%	45.70%	59.65%
GSK	GSK PLC	$80.96B	24.20%	5.80%	12.18%	16.10%	3.04	0.87	71.40%	10.80%	14.97%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.11B	19.20%	2.90%	12.45%	18.20%	5.96	1.08	57.70%	6.60%	21.45%
ELMD	ELECTROMED INC	$201.97M	17.50%	14.50%	23.73%	37.60%	0.25	4.31	78.10%	11.80%	16.07%
MDXG	MIMEDX GROUP INC	$1.03B	16.20%	12.00%	17.68%	40.40%	0.34	4.39	81.50%	8.80%	11.70%
AVDL	AVADEL PHARMACEUTICALS PLC	$1.49B	-3.70%	-1.70%	3.28%	4.70%	1.06	2.79	89.60%	-1.30%	1.93%
NBIX	NEUROCRINE BIOSCIENCES INC	$14.08B	13.20%	9.40%	15.76%	15.90%	0.44	3.20	98.50%	13.90%	21.00%
VTRS	VIATRIS INC	$11.10B	-19.90%	-8.50%	-10.40%	-14.20%	1.47	1.37	36.60%	-24.60%	-23.04%
SHC	SOTERA HEALTH CO	$4.49B	5.80%	0.80%	8.77%	7.10%	6.48	2.46	55.20%	2.20%	22.75%
KMDA	KAMADA LTD	$383.56M	7.40%	5.20%	6.05%	15.50%	0.42	4.00	43.60%	11.20%	11.51%
GRDN	GUARDIAN PHARMACY SERVICES INC	$1.65B	-61.50%	-26.90%	-36.56%	-60.30%	1.04	1.18	19.60%	-6.90%	-5.85%
BIIB	BIOGEN INC	$20.14B	9.00%	5.40%	7.15%	15.70%	0.61	2.50	75.40%	15.30%	17.98%
INVA	INNOVIVA INC	$1.19B	5.70%	3.00%	7.86%	9.00%	0.87	2.64	86.60%	10.40%	23.09%
MIRM	MIRUM PHARMACEUTICALS INC	$3.66B	-24.80%	-8.50%	-7.40%	-10.50%	1.85	3.13	79.00%	-13.60%	-10.02%
THC	TENET HEALTHCARE CORP	$17.85B	37.30%	5.10%	11.81%	13.00%	5.44	1.71	100.00%	7.20%	13.95%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$2.70B	1.00%	0.80%	2.62%	4.30%	0.34	3.57	85.90%	0.90%	2.69%
SPOK	SPOK HOLDINGS INC	$358.90M	11.10%	8.10%	13.89%	43.90%	0.38	1.24	79.60%	12.10%	16.11%
BHC	BAUSCH HEALTH COMPANIES INC	$2.40B	-8.90%	0.40%	8.12%	7.10%	-35.50	1.31	70.70%	1.00%	18.35%
CRMD	CORMEDIX INC	$766.42M	22.60%	17.00%	14.95%	53.00%	0.30	4.21	95.20%	20.80%	20.85%
NUTX	NUTEX HEALTH INC	$570.65M	57.60%	11.80%	20.74%	17.60%	2.47	2.27	48.80%	10.80%	19.45%
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$7.31B	-2.00%	-0.90%	1.48%	1.70%	1.24	1.36	32.50%	-1.70%	2.38%
PBYI	PUMA BIOTECHNOLOGY INC	$240.25M	49.30%	18.20%	39.47%	61.20%	1.02	1.53	72.40%	16.40%	18.58%
GMAB	GENMAB A	$18.65B	24.70%	19.90%	30.06%	75.00%	0.22	6.22	94.40%	37.60%	52.88%
SNN	SMITH & NEPHEW PLC	$15.54B	7.70%	3.90%	7.03%	8.30%	0.93	3.00	69.60%	7.10%	11.07%
MD	PEDIATRIX MEDICAL GROUP INC	$1.42B	14.10%	5.30%	10.21%	18.50%	1.52	1.80	24.40%	5.70%	9.26%
EW	EDWARDS LIFESCIENCES CORP	$44.77B	41.30%	31.60%	36.31%	71.50%	0.27	4.68	78.90%	73.00%	77.18%
AKBA	AKEBIA THERAPEUTICS INC	$719.62M	N/A	-18.90%	-9.98%	-30.20%	11.62	2.23	68.00%	-24.50%	-11.82%
IDXX	IDEXX LABORATORIES INC	$50.58B	64.40%	29.90%	59.89%	50.70%	1.28	1.11	61.50%	24.40%	31.25%
ALNY	ALNYLAM PHARMACEUTICALS INC	$58.51B	-274.20%	-7.40%	-6.96%	-4.50%	17.22	2.80	83.60%	-13.00%	-9.23%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$21.04B	-2.60%	-0.40%	3.19%	4.00%	4.88	1.06	49.60%	-1.00%	5.42%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.32B	N/A	-9.90%	-2.16%	-1.70%	-18.34	1.95	82.20%	-13.00%	-2.10%
LLY	ELI LILLY & CO	$685.75B	88.40%	16.00%	27.24%	22.10%	4.52	1.28	82.60%	25.90%	31.66%
FMS	FRESENIUS MEDICAL CARE AG	$15.01B	4.70%	2.00%	5.33%	5.90%	1.28	1.44	24.70%	3.40%	7.00%
VMD	VIEMED HEALTHCARE INC	$260.25M	10.50%	7.90%	14.12%	21.00%	0.31	1.48	58.30%	5.80%	8.63%
NAGE	NIAGEN BIOSCIENCE INC	$778.39M	35.50%	23.80%	26.49%	199.80%	0.43	3.88	63.60%	15.20%	15.76%
AHCO	ADAPTHEALTH CORP	$1.20B	5.20%	1.80%	7.02%	8.50%	1.74	1.06	22.00%	2.50%	8.08%
DH	DEFINITIVE HEALTHCARE CORP	$567.08M	-77.30%	-31.70%	-52.05%	-106.80%	1.18	1.65	76.40%	-124.40%	-131.52%
ELAN	ELANCO ANIMAL HEALTH INC	$9.74B	6.70%	3.30%	6.36%	10.60%	1.03	2.60	54.70%	9.70%	17.51%
KRMD	KORU MEDICAL SYSTEMS INC	$183.09M	-26.80%	-16.80%	-23.09%	-31.40%	0.54	2.91	63.20%	-12.30%	-12.20%
AXGN	AXOGEN INC	$789.58M	-4.40%	-2.30%	1.81%	1.50%	0.83	4.14	74.30%	-2.30%	1.60%
ONC	BEONE MEDICINES LTD	$35.91B	-5.10%	-3.00%	-2.23%	-4.10%	0.67	1.95	85.50%	-3.90%	-1.99%
AVNS	AVANOS MEDICAL INC	$546.16M	-50.40%	-37.40%	-51.86%	-96.70%	0.34	2.65	53.80%	-66.90%	-67.73%
OPRX	OPTIMIZERX CORP	$347.34M	-13.10%	-9.10%	-6.83%	-19.20%	0.44	2.82	64.10%	-16.30%	-10.81%
MMSI	MERIT MEDICAL SYSTEMS INC	$4.75B	8.50%	4.80%	7.62%	10.10%	0.74	4.09	47.90%	8.30%	12.56%
NVST	ENVISTA HOLDINGS CORP	$3.38B	1.80%	1.00%	3.18%	7.10%	0.81	2.44	54.70%	2.10%	6.07%
SNY	SANOFI	$115.05B	12.80%	7.20%	11.91%	27.80%	0.78	1.27	71.60%	21.20%	26.49%
OMCL	OMNICELL INC	$1.41B	1.80%	1.10%	1.00%	2.70%	0.70	1.42	43.70%	2.00%	1.34%
AMRN	AMARIN CORP PLC	$330.92M	-21.20%	-15.00%	-20.11%	-26.80%	0.44	3.26	37.50%	-47.20%	-44.38%
SOLV	SOLVENTUM CORP	$12.35B	12.30%	2.60%	6.25%	7.10%	3.45	1.19	54.60%	4.60%	8.99%
UHS	UNIVERSAL HEALTH SERVICES INC	$12.78B	18.60%	8.60%	14.27%	13.50%	1.12	1.29	42.00%	7.70%	10.98%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.64B	6.20%	4.70%	7.50%	21.60%	0.30	2.58	88.50%	9.70%	12.35%
EHC	ENCOMPASS HEALTH CORP	$12.76B	30.70%	9.80%	15.98%	14.00%	1.62	1.06	26.50%	11.50%	16.69%
IRMD	IRADIMED CORP	$893.83M	23.30%	20.60%	26.67%	70.60%	0.13	8.78	77.00%	26.60%	33.54%
PGNY	PROGYNY INC	$1.84B	11.80%	7.80%	17.52%	24.70%	0.56	2.39	22.00%	4.30%	7.12%
AORT	ARTIVION INC	$1.75B	-7.30%	-2.70%	1.56%	1.90%	1.69	5.53	63.90%	-5.50%	2.95%
INCY	INCYTE CORP	$16.15B	24.10%	15.80%	27.84%	62.90%	0.40	2.85	92.90%	19.00%	27.59%
PODD	INSULET CORP	$22.38B	18.40%	7.20%	13.03%	11.10%	1.37	2.26	70.70%	10.00%	13.58%
OPCH	OPTION CARE HEALTH INC	$4.43B	15.20%	6.20%	12.95%	17.40%	1.49	1.52	19.70%	3.90%	6.29%
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$307.19M	7.30%	5.30%	10.14%	17.90%	0.40	3.79	74.70%	5.10%	7.90%
GILD	GILEAD SCIENCES INC	$139.09B	32.90%	11.20%	18.42%	23.70%	1.84	1.32	78.50%	21.90%	28.42%
BWAY	BRAINSWAY LTD	$275.80M	9.00%	5.70%	9.19%	51.50%	0.64	3.51	74.50%	11.60%	17.17%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$2.11B	-62.60%	-25.20%	-29.82%	-25.00%	1.54	3.20	89.10%	-35.40%	-28.13%
GDRX	GOODRX HOLDINGS INC	$1.40B	5.10%	2.60%	8.49%	12.70%	1.05	4.21	93.70%	4.30%	12.61%
DVAX	DYNAVAX TECHNOLOGIES CORP	$1.17B	-9.80%	-6.00%	-5.55%	-4.40%	0.78	11.93	82.30%	-20.40%	-16.54%
XOMA	XOMA ROYALTY CORP	$443.38M	-15.30%	-5.60%	-2.21%	-2.40%	1.81	4.88	100.00%	-27.60%	-9.92%
TFX	TELEFLEX INC	$5.30B	4.50%	2.60%	4.92%	10.00%	0.74	2.41	55.60%	6.30%	10.78%
NVS	NOVARTIS AG	$239.37B	32.60%	13.30%	23.01%	40.10%	1.49	0.82	76.20%	24.70%	30.30%
PHR	PHREESIA INC	$1.42B	-8.70%	-6.10%	-7.53%	-41.40%	0.37	2.12	68.00%	-5.30%	-5.08%
HQY	HEALTHEQUITY INC	$8.32B	6.90%	4.20%	7.53%	19.60%	0.59	4.23	66.40%	11.50%	19.58%
SLGL	SOL-GEL TECHNOLOGIES LTD	$80.76M	-10.20%	-8.40%	-9.93%	-14.20%	0.23	7.32	100.00%	-14.20%	-14.25%
ZYME	ZYMEWORKS INC	$1.16B	-31.60%	-24.00%	-29.74%	-33.70%	0.31	4.71	100.00%	-121.70%	-114.77%
PCRX	PACIRA BIOSCIENCES INC	$1.13B	-16.50%	-8.20%	-7.18%	-7.60%	1.03	2.38	78.20%	-18.10%	-12.45%
HCA	HCA HEALTHCARE INC	$98.06B	-189.60%	10.00%	23.00%	12.80%	-13.83	0.98	40.90%	8.20%	13.79%
WST	WEST PHARMACEUTICAL SERVICES INC	$18.81B	17.70%	13.10%	18.27%	21.20%	0.35	2.78	35.30%	16.50%	20.66%
WGS	GENEDX HOLDINGS CORP	$3.37B	0.60%	0.30%	1.16%	1.90%	0.67	2.87	67.20%	0.40%	1.25%
ATRC	ATRICURE INC	$1.75B	-7.90%	-6.00%	-5.42%	-14.20%	0.31	3.94	74.70%	-7.30%	-5.85%
VRTX	VERTEX PHARMACEUTICALS INC	$98.90B	22.10%	15.90%	22.07%	31.10%	0.40	2.52	86.10%	31.90%	38.45%
FOLD	AMICUS THERAPEUTICS INC	$2.54B	-19.80%	-4.80%	3.89%	3.80%	2.99	3.21	90.40%	-6.70%	4.41%
FONR	FONAR CORP	$101.16M	4.60%	3.70%	5.74%	6.50%	0.33	8.45	41.10%	7.50%	10.99%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.79%	+1.91%	+6.43%	-34.10%	-103.63x	4.74x	-110.35%	-7.14%	-11.38%	+74.80%	Strong Buy
Diagnostics & Research	56	+1.01%	-2.91%	-2.11%	-20.34%	20.19x	3.68x	-3.05%	+7.21%	+15.74%	+12.47%	Strong Buy
Drug Manufacturers - General	19	+1.12%	-2.43%	-1.22%	-11.24%	36.82x	5.90x	+60.33%	+10.39%	+17.87%	+44.86%	Buy
Drug Manufacturers - Specialty & Generic	76	+0.80%	-1.60%	+0.72%	-14.92%	-26.18x	2.19x	+11.47%	+4.52%	+9.99%	+34.64%	Buy
Healthcare Plans	11	+0.51%	+2.09%	+1.67%	-31.43%	14.69x	2.04x	+15.83%	+4.97%	+11.53%	+16.07%	Buy
Health Information Services	53	+1.70%	-0.25%	-0.80%	-51.95%	79.61x	4.19x	+8.45%	+5.32%	+9.21%	+27.22%	Strong Buy
Medical Care Facilities	47	+1.83%	+4.11%	+3.99%	-27.10%	16.54x	5.02x	-187.08%	+6.89%	+15.30%	+13.48%	Buy
Medical Devices	142	+0.34%	-2.25%	-5.08%	-29.83%	30.11x	3.93x	+13.92%	+8.58%	+10.09%	+31.97%	Strong Buy
Medical Distribution	10	+2.95%	+6.64%	+8.45%	+42.42%	28.76x	311.71x	-10.64%	+3.09%	+19.03%	+11.15%	Buy
Medical Instruments & Supplies	55	+1.38%	-1.61%	-4.20%	-63.95%	29.83x	3.29x	+10.52%	+8.43%	+11.16%	+28.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 74.57% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 82.42% from Theravance Biopharma's current stock price of $14.07.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -4.34% over the past year, overperforming other healthcare stocks by 29 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 33.09% from Embecta's current stock price of $13.90.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 29, which is 4 points higher than the healthcare sector average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Infusystem Holdings has seen its stock return 57.62% over the past year, overperforming other healthcare stocks by 91 percentage points.

Infusystem Holdings has an average 1 year price target of $13.50, an upside of 30.56% from Infusystem Holdings's current stock price of $10.34.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.55%, which is 12 percentage points higher than the healthcare sector average of 2.08%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.33%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.89%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.36% in the last day, and up 0.15% over the last week. Bioaffinity Technologies was the among the top gainers in the healthcare sector, gaining 55.13% yesterday.

bioAffinity Technologies shares are trading higher after the company announced that it released three additional case studies, with one case study demonstrating that CyPath Lung led to detecting Stage 1A lung cancer.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.86% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -4.34% in the past year. It has overperformed other stocks in the healthcare sector by 29 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 89.06% in the past year. It has overperformed other stocks in the healthcare sector by 122 percentage points.

Are healthcare stocks a good buy now?

52.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.4% over the next year.

5.3% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.13% of healthcare stocks are rated B (Buy), 46.64% are rated C (Hold), 24.62% are rated D (Sell), and 11.31% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.